ALSA Ventures
London-based life science venture investor backing companies developing novel therapeutics, from company formation onwards.
- Venture capital
- London
- Type
- Venture capital
- Based in
- London
- Stages
- Seed, Series A, Series B+
- Sector focus
- Biotech & Life Sciences, Healthtech
- Fund size
- Undisclosed
- Founded
- 2019
- Website
- alsaventures.com
ALSA Ventures is an international life science fund manager headquartered on Pall Mall in London. It invests in biotechnology companies developing novel therapeutics across a broad range of disease areas and modalities, and is willing both to form new companies and to join syndicates alongside other investors. The investment team draws on backgrounds in the pharmaceutical, biotechnology and contract research industries, and works with portfolio companies from spin-out through to public listing. The firm's management company is authorised and regulated in the UK.
Team
- Alek Safarian, CEO LinkedIn
← All investors · Is this your organisation? Request an update
More investors in the directory
The Craftory
Purpose-driven consumer packaged goods brands with category-changing potential
Symvan Capital
EIS and SEIS funds backing B2B SaaS and technology companies from seed to exit
Grafton Capital
Growth capital for European software, AI and tech-enabled businesses
Blackfinch Ventures
EIS and VCT investment in early and growth-stage UK technology businesses
The Conduit Connect
Impact-led UK startups from pre-seed to Series A in climate, health and financial resilience
TrueSight Ventures
Angel-sized cheques at pre-seed and seed, sector-agnostic, into technology companies
Subscribe to Newsletter
Join me on this exciting journey as we explore the boundless world of web design together.